Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours; systematic review and economic evaluation

J Wilson; M Connock; F Song; GL Yao; A Fry-Smith; J Raftery; D Peake

Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours; systematic review and economic evaluation

J Wilson, M Connock, F Song, GL Yao, A Fry-Smith, J Raftery, D Peake

Research output: Contribution to journal › Article

55 Citations (Scopus)

Original language	English
Pages (from-to)	1-142
Number of pages	142
Journal	Health Technology Assessment
Volume	9
Issue number	25
Publication status	Published - 2005

Cite this

@article{4d453f2e197742f2af460ea3ab59329b,

title = "Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours; systematic review and economic evaluation",

author = "J Wilson and M Connock and F Song and GL Yao and A Fry-Smith and J Raftery and D Peake",

year = "2005",

language = "English",

volume = "9",

pages = "1--142",

journal = "Health Technology Assessment",

issn = "1366-5278",

publisher = "National Co-ordinating Centre for HTA",

number = "25",

}

TY - JOUR

T1 - Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours; systematic review and economic evaluation

AU - Wilson, J

AU - Connock, M

AU - Song, F

AU - Yao, GL

AU - Fry-Smith, A

AU - Raftery, J

AU - Peake, D

PY - 2005

Y1 - 2005

M3 - Article

VL - 9

SP - 1

EP - 142

JO - Health Technology Assessment

JF - Health Technology Assessment

SN - 1366-5278

IS - 25

ER -